210 related articles for article (PubMed ID: 33669781)
1. Mechanisms of Cisplatin in Combination with Repurposed Drugs against Human Endometrial Carcinoma Cells.
Lin CK; Liu ST; Wu ZS; Wang YC; Huang SM
Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33669781
[TBL] [Abstract][Full Text] [Related]
2. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endometrial cancer cell lines by mifepristone (RU 486).
Schneider CC; Gibb RK; Taylor DD; Wan T; Gerçel-Taylor C
J Soc Gynecol Investig; 1998; 5(6):334-8. PubMed ID: 9824816
[TBL] [Abstract][Full Text] [Related]
4. Palmitate Enhances the Efficacy of Cisplatin and Doxorubicin against Human Endometrial Carcinoma Cells.
Wu ZS; Huang SM; Wang YC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008502
[TBL] [Abstract][Full Text] [Related]
5. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2.
Cong L; Gasser J; Zhao J; Yang B; Li F; Zhao AZ
Endocr Relat Cancer; 2007 Sep; 14(3):713-20. PubMed ID: 17914101
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-alpha and insulin-like growth factor-I, but not epidermal growth factor, elicit autocrine stimulation of mitogenesis in endometrial cancer cell lines.
Reynolds RK; Hu C; Baker VV
Gynecol Oncol; 1998 Aug; 70(2):202-9. PubMed ID: 9740691
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
[TBL] [Abstract][Full Text] [Related]
8. In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs.
Hiramatsu HP; Kikuchi Y; Seto H; Nagata I
Anticancer Drugs; 2000 Aug; 11(7):573-8. PubMed ID: 11036961
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin Synergizes with Cisplatin in Antiendometrial Cancer Activation by Improving IL-27-Stimulated Cytotoxicity of NK Cells.
Zhou WJ; Chang KK; Wu K; Yang HL; Mei J; Xie F; Li DJ; Li MQ
Neoplasia; 2018 Jan; 20(1):69-79. PubMed ID: 29195127
[TBL] [Abstract][Full Text] [Related]
10. Antitumor Effects and Biological Mechanism of Action of the Aqueous Extract of the Camptotheca acuminata Fruit in Human Endometrial Carcinoma Cells.
Lin CS; Chen PC; Wang CK; Wang CW; Chang YJ; Tai CJ; Tai CJ
Evid Based Complement Alternat Med; 2014; 2014():564810. PubMed ID: 24963324
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of human choriocarcinoma spheroid attachment to uterine epithelial cell monolayers.
John NJ; Linke M; Denker HW
In Vitro Cell Dev Biol Anim; 1993 Jun; 29(6):461-8. PubMed ID: 27519747
[TBL] [Abstract][Full Text] [Related]
12. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
13. Human uterine epithelial RL95-2 and HEC-1A cell-line adhesiveness: the role of plexin B1.
Harduf H; Goldman S; Shalev E
Fertil Steril; 2007 Jun; 87(6):1419-27. PubMed ID: 17383649
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effects of 2-methoxyestradiol alone and in combination with chemotherapeutic agents on human endometrial cancer cells.
Chen CH; Lee WJ; Chang TC; Chen RJ; Chien CH; Chow SN
Eur J Gynaecol Oncol; 2009; 30(3):275-80. PubMed ID: 19697620
[TBL] [Abstract][Full Text] [Related]
15. Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance.
Ding N; Zhang H; Su S; Ding Y; Yu X; Tang Y; Wang Q; Liu P
Anticancer Agents Med Chem; 2018; 18(7):1054-1063. PubMed ID: 29256357
[TBL] [Abstract][Full Text] [Related]
16. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines.
Asgar MA; Senawong G; Sripa B; Senawong T
Int J Oncol; 2016 Jan; 48(1):409-20. PubMed ID: 26575528
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin against Human Endometrium Cancer Cells.
Karaboğa Arslan AK; Paşayeva L; Esen MA; Tugay O
Curr Pharm Biotechnol; 2022; 23(5):740-748. PubMed ID: 34445948
[TBL] [Abstract][Full Text] [Related]
18. Biogenesis of copper nanoparticles (Cu-NPs) using leaf extract of
Chinnathambi A; Awad Alahmadi T; Ali Alharbi S
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):500-510. PubMed ID: 34151675
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of human choriocarcinoma spheroid attachment to uterine epithelial cell monolayers.
John NJ; Linke M; Denker HW
In Vitro Cell Dev Biol Anim; 1993 Jun; 29A(6):461-8. PubMed ID: 8331030
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor expression in three different human endometrial cancer cell lines.
Lelle RJ; Talavera F; Gretz H; Roberts JA; Menon KM
Cancer; 1993 Jul; 72(2):519-25. PubMed ID: 8319182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
